Inventor
BHAVAR PRASHANT K
IN15 patents
⚠️ This page may combine multiple inventors who share the name “BHAVAR PRASHANT K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RHIZEN PHARMACEUTICALS SA
13 patentsUS10220035B2Mar 5, 2019
Compounds as modulators of protein kinases
RHIZEN PHARMACEUTICALS SA2 citations72
US9815831B2Nov 14, 2017
3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases
RHIZEN PHARMACEUTICALS SA5 citations71
US9783533B2Oct 10, 2017
Glutaminase inhibitors
RHIZEN PHARMACEUTICALS SA4 citations69
US11466006B2Oct 11, 2022
Dual selective PI3 delta and gamma kinase inhibitors
RHIZEN PHARMACEUTICALS SA0 citations62
US11020399B2Jun 1, 2021
Intermediates useful in the synthesis of compounds as modulators of protein kinases
RHIZEN PHARMACEUTICALS SA0 citations62
US11066402B2Jul 20, 2021
3,5-disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases
RHIZEN PHARMACEUTICALS SA0 citations61
US10851107B2Dec 1, 2020
Dual selective P13 delta and gamma kinase inhibitors
RHIZEN PHARMACEUTICALS SA0 citations51
US10322130B2Jun 18, 2019
Substituted chromenones as modulators of protein kinases
RHIZEN PHARMACEUTICALS SA0 citations51
US10179786B2Jan 15, 2019
Selective dual inhibitors of PI3 delta and gamma protein kinases
RHIZEN PHARMACEUTICALS SA0 citations51
US9758474B2Sep 12, 2017
Immunomodulator and anti-inflammatory compounds
RHIZEN PHARMACEUTICALS SA1 citations51
US9708329B2Jul 18, 2017
Selective dual inhibitors of PI3 delta and gamma protein kinases
RHIZEN PHARMACEUTICALS SA0 citations51
US10611759B2Apr 7, 2020
Glutaminase inhibitors
RHIZEN PHARMACEUTICALS SA0 citations50
US9790224B2Oct 17, 2017
Dual selective PI3 delta and gamma kinase inhibitors
RHIZEN PHARMACEUTICALS SA0 citations50